FK506 conversion for intractable rejection of the liver allograft Sue V. McDiarmidGoran B. KlintmalmRonald W. Busuttil Original Articles Pages: 305 - 312
Living related liver transplantation across ABO blood groups with FK506 and OKT3 Yukihiko TokunagaKoichi TanakaKazue Ozawa Original Articles Pages: 313 - 318
Conversion from cyclosporin to FK 506 after liver transplantation M. WinklerB. RingeR. Pichlmayr Original Articles Pages: 319 - 324
Hepatic arterial variations and liver-related diseases of 100 consecutive donors Heikki MäkisaloEleazar ChaibSir Roy Calne Original Articles Pages: 325 - 329
Evidence that both cyclosporin and azathioprine prevent warm ischemia reperfusion injury to the rat liver Katsunori KawanoYang Il KimMichio Kobayashi Original Articles Pages: 330 - 336
Single-shot, high-dose rabbit ATG for rejection prophylaxis after kidney transplantation R. ZietseE. P. M. van SteenbergeW. Weimar Original Articles Pages: 337 - 340
Cytomegalovirus infection accelerates cardiac allograft vasculopathy: correlation between angiographic and endomyocardial biopsy findings in heart transplant patients Petri K. KoskinenMarkku S. NieminenIrmeli T. Lautenschlager Original Articles Pages: 341 - 347
Renal transplantation in patients with bilateral renal carcinoma — how long should we wait? C. WigginsA. R. PontinD. Kahn Original Articles Pages: 348 - 349
Kidney transplantation in patients previously treated for renal carcinomas Israel Penu Invited Comment Pages: 350 - 350
Binding and specificity of major immunoglobulin classes of preformed human anti-pig heart antibodies E. KorenF. A. NeethlingD. K. C. Cooper Brief Reports Pages: 351 - 353
Liver transplantation for PNH with Budd-Chiari syndrome N. SchattenforhW. O. BechsteinP. Neuhaus Brief Reports Pages: 354 - 358